You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

FLECTOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Flector patents expire, and what generic alternatives are available?

Flector is a drug marketed by Ibsa and is included in one NDA.

The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FLECTOR?
  • What are the global sales for FLECTOR?
  • What is Average Wholesale Price for FLECTOR?
Summary for FLECTOR
Drug patent expirations by year for FLECTOR
Drug Prices for FLECTOR

See drug prices for FLECTOR

Drug Sales Revenue Trends for FLECTOR

See drug sales revenues for FLECTOR

Recent Clinical Trials for FLECTOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fidia Farmaceutici s.p.a.Phase 3
Fidia Farmaceutici s.p.a.Phase 1
Actavis Inc.Phase 3

See all FLECTOR clinical trials

Pharmacology for FLECTOR
Paragraph IV (Patent) Challenges for FLECTOR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FLECTOR Topical Patch diclofenac epolamine 1.3% 021234 1 2015-06-26

US Patents and Regulatory Information for FLECTOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ibsa FLECTOR diclofenac epolamine SYSTEM;TOPICAL 021234-001 Jan 31, 2007 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for FLECTOR

See the table below for patents covering FLECTOR around the world.

Country Patent Number Title Estimated Expiration
Greece 3002386 ⤷  Sign Up
European Patent Office 0621263 Préparation pour sparadrap analgésique et anti-inflammatoire externe (External anti-inflammatory and analgesic plaster preparation) ⤷  Sign Up
South Korea 960003327 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.